Case Report
Twenty-One Episodes of Peritonitis in a Continuous Ambulatory
peritonitis and 10 episodes of culture-positive peritonitis with Enterococcus faecalis, Staphylococcus saprophyticus and Escherichia coli. She was treated with appropriate antibiotics as per the ISPD guidelines. [1] She never reported previously any exit-site or tunnel infection. Her bowels were normal and she had no melena. In January 2018, due to an episode of refractory peritonitis, CAPD was discontinued and switched over to HD using a temporary jugular access. She received 1 g of intravenous vancomycin 2 days prior to presentation.
On examination, her blood pressure was 80/50 mmHg, she had no abdominal tenderness, the catheter exit site was normal and there was no tunnel tenderness. A clear dialysate effluent fluid that drained after 4 h of indwell time was sent for culture and it showed no growth after 48 h. It was also negative by polymerase chain reaction for Mycobacterium tuberculosis.
Ultrasound of the tunnel catheter did not show any tunnel collection. We proceeded with a laparoscopic examination of the peritoneal cavity which showed a normal-appearing peritoneum, a cirrhotic liver and minimal ascites without adhesions [ Figure 2 ]. In view of the normally appearing dialysate effluent with no excessive cell count, we replaced the catheter with a new swan-neck Tenckhoff double-cuff catheter through a different exit in the same sitting. Catheter-tip biofilm culture isolated Enterococcus casseliflavus [ Figure 3a and b], identified by Vitek II Compact, bioMerieux, France. Biopsy of the peritoneum showed fibrosis and no granulomas. HIV, hepatitis B and hepatitis C were negative. Two weeks later, CAPD was reinitiated and she received 2 g of intraperitoneal immunoglobulin in two separate doses with a dwell of 6 h as treatment for recurrent peritonitis in the form of empirical therapy. She is currently on APD for 5 months. She has good ultrafiltration (UF) and her daily UF varies between 1500 and 1800 cc/24 h.
DiscussiOn
The peritoneum is made up of six sites of anatomical resistance, with the vascular endothelium and the interstitium offering the maximum resistance, hence they are the key determinants of effective PD. [3] In PD patients, there is activation of peritoneal macrophages, mesothelium and daily loss of macrophages and immunoglobulins, thereby leading to impaired host defence, and hence increases susceptibility to infection. Uraemia, peritonitis, volume loading, the presence of a catheter and the PD fluid all initiate recruitment and activation of peritoneal cells such as macrophages, mast cells, mesothelial cells, fibroblasts and endothelial cells. This leads to the development of angiogenesis, fibrosis and membrane failure. [4] PD-related peritonitis is the main complication of PD, with increased morbidity and mortality. [5] Most studies reported infection rate as number of episodes/patient/year. The reported overall rate of PD-associated infection is 0.24-1.66 episodes/patient/year. [6] This patient had 21 episodes of PD peritonitis in 6.5 years, among which were several episodes of recurrent peritonitis, one episode of relapsing peritonitis and 1 episode of refractory peritonitis as per the definition of ISPD. [1] The diagnosis of PD peritonitis was defined by abdominal pain with a cloudy dialysis effluent and the presence of >100 white cell count/µL of dialysis effluent with >50% polymorphonuclear cells, with or without a positive effluent culture. Severe or prolonged peritonitis leads to structural and functional alterations of the peritoneal membrane, eventually leading to membrane failure. [1] Despite having minimal peritoneal fibrosis, she has adequate UF probably due to inadequate biopsy sampling not reflective of the state of the entire peritoneum or due to ascites caused by portal hypertension. Although liver cirrhosis could lead to dysfunction of Kupffer cells and presence of portal-systemic shunts, the pathogen which we isolated is a rare cause of SBP. [7] Diverticulosis was not ruled out; however, she never reported constipation or diarrhoea or blood in the stools. The patient's PD technique was adequate and she was on a double-bag disposal system. Anterior nares' culture was negative for methicillin-resistant S. aureus.
The ISPD recommends that timely catheter removal be considered for relapsing, recurrent or refractory peritonitis episodes. Furthermore, it is recommended that the PD catheter be removed promptly in refractory peritonitis episodes, defined as failure of the PD effluent to clear up after 5 days of appropriate antibiotics, [1] to avoid membrane failure and most especially mortality.
E. casseliflavus is a rare non-faecium, non-faecalis, intrinsic low-level vancomycin-resistant Enterococcus responsible for 2% of all enterococcal infections. It has been reported to cause nosocomial bacteraemia, urinary infections and rarely SBP in elderly patients. This case is presented for demonstrating the laparoscopic view of the peritoneum in a patient with 21 episodes of peritonitis and usefulness of biofilm culture of the catheter tip. There are no reports in literature of a patient with 21 episodes of peritonitis.
cOnclusiOn
Peritonitis is the most frequent and serious infection-related complication of PD. Recurrent, relapsing and refractory peritonitis may lead to structural and functional alterations of the peritoneal membrane and eventually membrane failure. This patient had 21 episodes of PD peritonitis in 6.5 years, biofilm culture revealed the source of infection. Here, we report a rare case with recurrent episode of peritonitis which was due to biofilm and removal and replacement of the catheter with successful re-initiation of APD. [8] The root cause analysis enhances the understanding of PD-site maintenance for the clinical microbiologists.
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